Inovio Pharmaceuticals, Inc.

LSE:0A43 株式レポート

時価総額:US$141.5m

Inovio Pharmaceuticals 過去の業績

過去 基準チェック /06

Inovio Pharmaceuticals's earnings have been declining at an average annual rate of -5.2%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 7% per year.

主要情報

-5.2%

収益成長率

13.8%

EPS成長率

Biotechs 業界の成長11.5%
収益成長率-7.0%
株主資本利益率-125.7%
ネット・マージン-20,552.3%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

収支内訳

Inovio Pharmaceuticals の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

LSE:0A43 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 241-122410
31 Mar 241-125450
31 Dec 231-135480
30 Sep 231-165370
30 Jun 2310-168390
31 Mar 2310-241730
31 Dec 2210-280760
30 Sep 2211-332900
30 Jun 222-355920
31 Mar 222-328560
31 Dec 212-304540
30 Sep 217-221480
30 Jun 216-142450
31 Mar 216-188440
31 Dec 207-166370
30 Sep 202-180370
30 Jun 203-222330
31 Mar 203-123280
31 Dec 194-119270
30 Sep 196-115240
30 Jun 197-117250
31 Mar 1932-94270
31 Dec 1830-97290
30 Sep 1837-86320
30 Jun 1837-95310
31 Mar 1833-97300
31 Dec 1742-88280
30 Sep 1742-93270
30 Jun 1752-80270
31 Mar 1738-89260
31 Dec 1635-74240
30 Sep 1633-65220
30 Jun 1644-39200
31 Mar 1644-27190
31 Dec 1541-29180
30 Sep 1537-19170
30 Jun 1515-31160
31 Mar 1513-36160
31 Dec 1410-36160
30 Sep 1410-44160
30 Jun 1417-68160
31 Mar 1414-68150
31 Dec 1313-66140

質の高い収益: 0A43 is currently unprofitable.

利益率の向上: 0A43 is currently unprofitable.


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 0A43 is unprofitable, and losses have increased over the past 5 years at a rate of 5.2% per year.

成長の加速: Unable to compare 0A43's earnings growth over the past year to its 5-year average as it is currently unprofitable

収益対業界: 0A43 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).


株主資本利益率

高いROE: 0A43 has a negative Return on Equity (-125.74%), as it is currently unprofitable.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘